|
|
Volumn 162, Issue 14, 2002, Pages 1568-1576
|
|
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: Results of the assessment of diabetes control and evaluation of the efficacy of Niaspan trial
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FATTY ACID;
GLYCOSYLATED HEMOGLOBIN;
HIGH DENSITY LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
NICOTINIC ACID;
PLACEBO;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES CONTROL;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSLIPIDEMIA;
FEMALE;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
HUMAN;
INSULIN RESISTANCE;
LIPID METABOLISM;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
ADULT;
AGED;
ANTILIPEMIC AGENTS;
BIOLOGICAL MARKERS;
BLOOD GLUCOSE;
BODY MASS INDEX;
C-REACTIVE PROTEIN;
CHOLESTEROL, HDL;
CHOLESTEROL, LDL;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
ENDPOINT DETERMINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
MALE;
MIDDLE AGED;
NIACIN;
TREATMENT OUTCOME;
TRIGLYCERIDES;
UNITED STATES;
|
|
EID: 0037158150
PISSN: 00039926
EISSN: None
Source Type: Journal
DOI: 10.1001/archinte.162.14.1568 Document Type: Article |
|
Times cited : (506)
|
|
References (26)
|
